Veröffentlichungen

Publikationsliste 2017

Zentrum für Qualitätssicherung und Versorgungsforschung (ZeQV)
der Universität Regensburg

Papathemelis, T., Scharl, S., Kronberger, K., Gerken, M., Scharl, A., Pauer, A., Klinkhammer-Schalke, M., 2017. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J. Cancer Res. Clin. Oncol. 143, 2555–2562.

https://doi.org/10.1007/s00432-017-2508-1

Scharl, S., Papathemelis, T., Kronberger, K., Koelbl, O., Scharl, A., Gerken, M., Klinkhammer-Schalke, M., 2017. Recurrence-free survival is improved through adjuvant treatment with concomitant radio-chemotherapy and systematic lymphonodectomy in high grade endometrial cancer patients. Results of a population-based cohort analysis of a cancer registry. Strahlenther. Onkol. 193, S93–S93.

https://www.webofscience.com/wos/woscc/full-record/WOS:000416389400199

Benz, S., Barlag, H., Gerken, M., Fuerst, A., Klinkhammer-Schalke, M., 2017. Laparoscopic surgery in patients with colon cancer: a population-based analysis. Surg. Endosc. 31, 2586–2595.

https://doi.org/10.1007/s00464-016-5266-2

Haj, A., Doenitz, C., Schebesch, K.-M., Ehrensberger, D., Hau, P., Putnik, K., Riemenschneider, M.J., Wendl, C., Gerken, M., Pukrop, T., Brawanski, A., Proescholdt, M.A., 2017. Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sciences 8, 5.

https://doi.org/10.3390/brainsci8010005

Inwald, E.C., Ortmann, O., Koller, M., Zeman, F., Hofstaedter, F., Evert, M., Brockhoff, G., Klinkhammer-Schalke, M., 2017. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res. Treat. 163, 119–130.

https://doi.org/10.1007/s10549-017-4151-6

Kirzinger, L., Schneider, R., Mayer, C., Schoetz, S., Backhaus, R., Gerken, M., Klinkhammer-Schalke, M., Schalke, B., 2017. The influence of thymoma- surgery on paraneoplastic myasthenia gravis. J. Neurol. Sci. 381, 474–474.

https://doi.org/10.1016/j.jns.2017.08.3545

Klinkhammer-Schalke, M., Gerken, M., Barlag, H., Hofstaedter, F., Benz, S., 2017b. Importance of the cancer registry in health care research. Registry studies vs. clinical studies using the example of colon cancer. Onkologe 23, 280–287.

https://doi.org/10.1007/s00761-016-0181-7

Klinkhammer-Schalke, M., Lindberg, P., Steinger, B., Koller, M., 2017c. Safety and feasibility of a quality of life intervention in a randomized controlled trial on patients with colorectal cancer. J. Clin. Oncol. 35.

https://doi.org/10.1200/JCO.2017.35.15_suppl.e18200

Klinkhammer-Schalke, M., Steinger, B., Koller, M., Lindberg, P., 2017d. Lebensqualitätsinterventionen in der Onkologie. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 122, 48–52.

https://doi.org/10.1016/j.zefq.2017.04.005

Lindberg, P., Netter, P., Koller, M., Steinger, B., Klinkhammer-Schalke, M., 2017. Breast cancer survivors’ recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial. PLoS One 12, e0171519.

https://doi.org/10.1371/journal.pone.0171519

Loechelt, A.C., Gerken, M., Koelbl, O., 2017. Incidence and Therapy of Brain Metastases. An Analysis of 198,799 Patients in a population-based Cancer Registry. Strahlenther. Onkol. 193, S42–S42.

https://www.webofscience.com/wos/woscc/full-record/WOS:000416389400085